TGCT Support
  • Home
  • About TGCT
    • Types of TGCT
    • Tumor Location
    • Causes of TGCT
    • Diagnosis >
      • Imaging Features
      • Biopsy
  • Treatment
    • Surgery >
      • Recovery
    • Medication
    • Clinical Trials >
      • Vimseltinib
      • AMB-05X
      • Cabiralizumab
      • Emactuzumab
    • Radiation
  • Get Support
    • Join the Community >
      • Volunteer
      • Support Groups
    • TGCT Specialists
    • Nutrition
    • Pain Management
    • Side Effect Management
    • Glossary of Terms
    • Educational Materials & Videos
    • Webinars
  • News
    • Patient Stories
  • About Us
    • Meet the Team
    • Contact Us
    • Our Store
  • DONATE
  • Home
  • About TGCT
    • Types of TGCT
    • Tumor Location
    • Causes of TGCT
    • Diagnosis >
      • Imaging Features
      • Biopsy
  • Treatment
    • Surgery >
      • Recovery
    • Medication
    • Clinical Trials >
      • Vimseltinib
      • AMB-05X
      • Cabiralizumab
      • Emactuzumab
    • Radiation
  • Get Support
    • Join the Community >
      • Volunteer
      • Support Groups
    • TGCT Specialists
    • Nutrition
    • Pain Management
    • Side Effect Management
    • Glossary of Terms
    • Educational Materials & Videos
    • Webinars
  • News
    • Patient Stories
  • About Us
    • Meet the Team
    • Contact Us
    • Our Store
  • DONATE

News

What's new?

Picture
TGCT Support supports patients with video for Rare Disease Day

Watch here 

Picture
First Western US to open Phase 3 for Vimseltinib 

​Check it out here



Picture
Director of Giant Cell Tumor Programs at TGCT Support, Sydney Stern, gives an overview of TGCT for CheckRare

​                       Check it out!


Picture
AmMax Bio announces positive results during AMB-05X Phase 2 trial of local injections to the knee

                           Learn more here


Picture
DCC-3014 (Vimseltinib) launches its Phase 3 Trial

Learn more here

Picture
TGCT Support Launches Support Groups!

Check it out here
​

Picture
National Organization for Rare Diseases (NORD) updates their TGCT page
​
Check it out here


Picture
AmMax Bio Announces First Patient Enrolled in Phase 2 Trial of AMB-05X for Tenosynovial Giant Cell Tumor (TGCT)

Read more here

Picture
CancerCare® Publishes White Paper Highlighting Gaps in Education and Care for Patients with Tenosynovial Giant Cell Tumors (TGCT)

Read more here


Picture
DCC-3014 (vimseltinib) shows promise as a new selective treatment for TGCT

Read more here

Picture
New Clinical Trial from AmMax Bio for an intra-articular joint injection for TGCT patients

Read more here

TGCT SUPPORT IS A PROGRAM OF THE LIFE RAFT GROUP

Picture
155 US Highway 46, Suite 202                      Wayne, NJ 07470                      support@tgctsupport.org